1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials

E Grist,L Mendes,N.D James,W Cross,A.A Hamid,M.A Parry,L.C Brown,E Davicioni,F Feng,D.M Berney,N Clarke,S Gillessen,C.L Amos,M.K Parmar,A Sachdeva,P Dutey-Magni,C Sweeney,M.R Sydes,J Proudfoot,G Attard

doi:10.1016/j.annonc.2024.08.1677

1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials

E Grist, L Mendes + Show 18 more

https://doi.org/10.1016/j.annonc.2024.08.1677

Copy DOI

Journal: Annals of Oncology

Publication Date: Sep 1, 2024

#Start Of Androgen Deprivation Therapy #Androgen Deprivation Therapy + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.